Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jade Wind-Barrier Herbal Tea Bag for Common Cold Prevention in Elderly
NCT05640570Phase 2Completed
- Sponsor
- Hong Kong Baptist University
- Start
- Feb 2022
- Primary completion
- Aug 2022
- Modality
- Microbiome Therapeutics, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of yupingfeng in common cold (2 arms), sponsored by Hong Kong Baptist University. Primary endpoints: Change in the incidence rate of the common cold at 13 weeks and Change in the reductive ratio of the total score of CFQCQ at 13 weeks. Started Feb 2022; status: completed.
02
Drugs
yupingfeng
03
Conditions
common cold
Beyond the preview
Go deeper on NCT05640570.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05640570.